Glaucoma products in the pipeline for Aerie

CHICAGO – At the Ophthalmology Innovation Summit, Vicente Anido Jr., PhD, CEO of Aerie Pharmaceuticals discusses the company’s strategy for focusing on glaucoma at present in order to become a major ophthalmology company.